Companies: 10,795·Total market cap: $144.5T
BrainsWay Ltd.

BrainsWay Ltd.

BWAYNASDAQHealthcare● Active
$14.49
+$0.60(+4.32%)
Market Cap$568341270
P/E Ratio—
52W High$17.352
52W Low$5.105
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

BrainsWay Ltd. (BWAY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001505065 · BWAY · NASDAQ · as of Jun 8, 2026

Filing snapshot

263
Total Filings
4
Latest Form
2026-06-03
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001505065 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-20
Fiscal Year End
Apr 20, 2026
Accession No.
0001171843-26-002568
Primary Document
f20f_032726.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001505065 · Accession 0001171843-26-002568

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-05-18
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-18
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-05
View
S-8Employee Stock Plan Registration
FORM S-8
2026-04-20
View
S-8 POSS-8 POS
FORM S-8 POS
2026-04-20
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2026-04-20
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-06
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-19
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
Showing 1–15 of 260 filingsForm 4 / 144 hidden· 263 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001505065  |  Exchange: NASDAQ · Healthcare

BrainsWay Ltd. (NASDAQ: BWAY) has submitted 263 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001505065, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BrainsWay Ltd.'s most comprehensive regulatory disclosure. The most recent BrainsWay Ltd. 10-K was filed on 2026-04-20 for fiscal year ending 2026. Historical BWAY 10-K annual reports are available from 2011 through 2026.

Investors researching BrainsWay Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
TCMD SEC Filings →NPCE SEC Filings →CERS SEC Filings →VMD SEC Filings →DCTH SEC Filings →MASS SEC Filings →SENS SEC Filings →SGHT SEC Filings →
→ BWAY Financials→ BWAY Earnings→ BWAY Insider Trades

Frequently Asked Questions

BWAY SEC Filings · 8 questions

BrainsWay Ltd. (BWAY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 263 filings and access original documents at no cost. BrainsWay Ltd.'s CIK is 0001505065.

BWAY SEC filingsBrainsWay Ltd. SEC documentsfind BWAY 10-K